Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Regeneron Acquires Hearing Loss Biotech in $213M Deal

Headphones sound waves graphic

Regeneron Pharmaceuticals, a maker of synthetic biologic treatments, is acquiring Decibel Therapeutics, developer of gene therapies to treat hearing loss and balance disorders. . . . → Read More: Regeneron Acquires Hearing Loss Biotech in $213M Deal

Companies to Assess Ovarian Health Biotech Drug

Women silhouettes

A women’s health biotechnology company is partnering with a Brazilian drug maker to evaluate a precision target and treatment for ovarian health disorders. . . . → Read More: Companies to Assess Ovarian Health Biotech Drug

Companies Partner on Fast Production of Biologics in Plants

Flowering Nicotiana benthamiana plant

The developer of a biologic drug-making process with engineered plant crops is collaborating with a vertical farming company to create a network of biologics production facilities. . . . → Read More: Companies Partner on Fast Production of Biologics in Plants

Streamlined Gene Therapy Delivery Process Demonstrated

Sickle cells illustration

A group of academic and industry researchers exhibited in lab cells and mice a more direct delivery technique that could make gene therapies more accessible and inexpensive. . . . → Read More: Streamlined Gene Therapy Delivery Process Demonstrated

One-Time Crispr HIV Therapy Given Fast-Track Status

T-cell infected by HIV

A treatment for HIV taken just once, using the genome-editing technology Crispr, is receiving fast-track designation from the U.S. Food and Drug Administration. . . . → Read More: One-Time Crispr HIV Therapy Given Fast-Track Status

Darpa Seeking On-Demand, Distributed Production of Proteins

Aerial view of the Pentagon in Washington, D.C.

A synthetic biology company is receiving a contract with the U.S. advanced defense research agency to devise a high-speed localized process for making therapeutic proteins. . . . → Read More: Darpa Seeking On-Demand, Distributed Production of Proteins

NIH Funding Single Home Test for Covid-19, Influenza, RSV

Co-Dx PCR Home test

A developer of diagnostics for infectious and other diseases is receiving a National Institutes of Health contract to advance a single at-home test for multiple respiratory diseases. . . . → Read More: NIH Funding Single Home Test for Covid-19, Influenza, RSV

Synthetic DNA Company Gains $10M in Venture Round

Steve Harvey and Derek Stemple in the lab

A company using a process it says can produce synthetic genes with greater accuracy for research and clinical applications is raising $10 million in its first venture round. . . . → Read More: Synthetic DNA Company Gains $10M in Venture Round

Engineered T-Cells Shown Safe, Reduce Myasthenia Gravis

T-cell lymphocyte

Results of a small clinical trial show genetically altered T-cells from patients with myasthenia gravis are well tolerated and reduce symptoms of the disease. . . . → Read More: Engineered T-Cells Shown Safe, Reduce Myasthenia Gravis

Patent Issued for Synthetic Peptide Chain Techniques

U.S. Patent and Trademark Office

A new U.S. patent, licensed to a start-up biotechnology company, describes processes for linking together chains of synthetic peptides into therapeutic proteins. . . . → Read More: Patent Issued for Synthetic Peptide Chain Techniques